MIRAMAR, Fla. – A clinical trial by the National Institutes of Health could provide a breakthrough treatment for food allergies.
Dr. Christopher Chang, Chief of the Allergy and Immunology Program at Joe DiMaggio Children’s Hospital, said the trial actually had three phases.
Benefits were seen from the combination of an FDA approved lab-made antibody in conjunction with oral immunotherapy.
“I think it’s really exciting for people with food allergies. My daughter has a food allergy. She’s an adult now but when she was growing up, she didn’t have any of these new therapies that are available now and so for our kids now, our children now, who have food allergies this is really, really exciting,” he said.
Chang said the trial found that participants who received doses of the monoclonal antibody could consumer higher doses of peanut, egg, milk, and cashew without allergic reactions than participants who received the placebo injections.
YOUTH ANTIDEPRESSANT USE SOARS
The number of young people requiring prescriptions for depression or anxiety skyrocketed since the pandemic.
According to a new study in the Journal Pediatrics, the number of people ages 12 to 25 was already growing but since COVID, the dispensing rate rose almost 64- percent more than normal and more than 130-percent for young women.
Experts say while the rise in numbers is alarming... Anti-depressants can be lifesaving.
Mental health specialists say parents need to be aware of any changes in their child’s behavior or mood change.
Other warning signs include changes in sleep, social life, attitude, school performance, ability to concentrate or interest in activities.